Form SC 13E3/A Filings
SEC Form SC 13E3/A is an amendment filing used to update or supplement a previously filed Schedule 13E-3 in connection with a Rule 13e-3 going-private transaction. It is filed when material changes, additional disclosures, or transaction developments need to be reflected in the original filing.
| Form | Filer Name | Filing Agent | Date | Actions | |
|---|---|---|---|---|---|
| SC 13E3/A | Cloopen Group Holding Ltd | M2 Compliance Llc /fa | 08/11/2026 | ||
| SC 13E3/A | Kore Group Holdings, Inc. | Broadridge Financial Solutions, Inc. /fa | 07/21/2026 | ||
| SC 13E3/A | Ihs Holding Ltd | Toppan Merrill/fa | 07/10/2026 | ||
| SC 13E3/A | Cosciens Biopharma Inc. | M2 Compliance Llc /fa | 07/06/2026 | ||
| SC 13E3/A | Select Medical Holdings Corp | Toppan Merrill/fa | 07/01/2026 | ||
| SC 13E3/A | Aptose Biosciences Inc. | Donnelley Financial Solutions /fa/ | 07/01/2026 | ||
| SC 13E3/A | Janus Henderson Group Plc | Toppan Merrill/fa | 06/30/2026 | ||
| SC 13E3/A | Ihs Holding Ltd | Toppan Merrill/fa | 06/26/2026 | ||
| SC 13E3/A | Clearwater Analytics Holdings, Inc. | Donnelley Financial Solutions /fa/ | 06/25/2026 | ||
| SC 13E3/A | Lakeshore Biopharma Co., Ltd. | Self | 06/24/2026 | ||
| Load More | |||||
